|
VAV2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.24759996672697E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.82170000037918E-07 |
| Normal-vs-Stage2 |
1.37520000054181E-07 |
| Normal-vs-Stage3 |
1.52699999977912E-07 |
| Normal-vs-Stage4 |
4.17660350748861E-11 |
| Stage1-vs-Stage2 |
1.904650E-01 |
| Stage1-vs-Stage3 |
2.386000E-01 |
| Stage1-vs-Stage4 |
1.241680E-03 |
| Stage2-vs-Stage3 |
7.069600E-01 |
| Stage2-vs-Stage4 |
2.093600E-01 |
| Stage3-vs-Stage4 |
6.768200E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.51019996297697E-09 |
| Normal-vs-AfricanAmerican |
7.090200E-02 |
| Normal-vs-Asian |
3.85010000000241E-05 |
| Caucasian-vs-AfricanAmerican |
3.124600E-01 |
| Caucasian-vs-Asian |
7.009200E-01 |
| AfricanAmerican-vs-Asian |
4.592000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.89189999999506E-06 |
| Normal-vs-Female |
1.5607000136697E-09 |
| Male-vs-Female |
3.419600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.44300000004538E-06 |
| Normal-vs-Age(41-60Yrs) |
2.33960000262101E-08 |
| Normal-vs-Age(61-80Yrs) |
3.22350035553143E-10 |
| Normal-vs-Age(81-100Yrs) |
8.201000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.941200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.589700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.053600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.109200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.061600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.361600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.580700E-03 |
| Classical-VS-Follicular |
1.897820E-02 |
| Classical-VS-Other |
9.630600E-01 |
| Classical-VS-Normal |
1.79219999951741E-07 |
| Tall-VS-Follicular |
7.019400E-01 |
| Tall-VS-Other |
5.184000E-01 |
| Tall-VS-Normal |
3.12540000546591E-08 |
| Follicular-VS-Other |
4.402400E-01 |
| Follicular-VS-Normal |
4.25739999920793E-08 |
| Other-VS-Normal |
2.789000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.76839999813205E-08 |
| Normal-vs-N1 |
4.28980000410917E-08 |
| N0-vs-N1 |
3.188200E-01 |
|
|
